Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
VX-661 F508del CFTR Corrector: Advanced Bench Applications
2026-07-06
VX-661 (F508del CFTR corrector) is a gold-standard tool for restoring CFTR function in cystic fibrosis models, enabling repeatable, quantitative workflows for protein trafficking and membrane localization studies. Recent advances in calnexin-dependent rescue and variant profiling have propelled VX-661 into the center of precision CF research.
-
Macrophage-EV miR-660 Promotes Breast Cancer via KLHL21/NF-κ
2026-07-06
This study elucidates how tumor-associated macrophage-derived extracellular vesicles (EVs) containing microRNA-660 drive breast cancer progression by targeting KLHL21 and activating the NF-κB p65 pathway. The findings highlight a novel, clinically relevant mechanism of tumor-immune crosstalk, providing new insights for research on metastatic breast cancer and tumor microenvironment signaling.
-
Applied Use of α-Linolenic Acid in Experimental Lipid Resear
2026-07-05
Harness α-Linolenic Acid (ALA) for precision-driven lipid metabolism, cardiovascular, and inflammation studies. Discover streamlined protocols, troubleshooting strategies, and actionable assay enhancements informed by cutting-edge immune research.
-
Annexin V-FITC/PI Apoptosis Assays: Decoding Apoptosis Resis
2026-07-04
Explore the mechanistic and translational significance of Annexin V-FITC/PI Apoptosis Assay Kits for detecting apoptosis resistance in lung adenocarcinoma. This article provides actionable strategies for translational researchers, integrating the latest evidence on PAR2-mediated apoptosis evasion, competitive benchmarking, and practical guidance for maximizing experimental rigor using tools like the APExBIO Annexin V-FITC/PI Apoptosis Assay Kit.
-
Neurotensin (CAS 39379-15-2): Advanced Insights for GPCR and
2026-07-03
Unlock the molecular detail of Neurotensin as a Neurotensin receptor 1 activator. Discover new depth on its role in GPCR trafficking and miRNA regulation, with actionable insights for gastrointestinal research and advanced assay design.
-
Meropenem in Resistance Research: Protocols & Troubleshootin
2026-07-03
Meropenem, a β-lactam antibiotic carbapenem, empowers resistance modeling and in vivo efficacy benchmarking against both Gram-negative and Gram-positive pathogens. This guide details applied workflows, experimental optimization, and troubleshooting for Meropenem-based studies—anchored by new insights into carbapenemase gene transfer in Enterobacter cloacae.
-
Ectomesenchymal Stem Cells Modulate Microglia After ICH
2026-07-02
This study demonstrates that ectomesenchymal stem cell (EMSC) transplantation from nasal mucosa promotes anti-inflammatory microglial polarization and increases IL-10 secretion, mitigating neuroinflammation after intracerebral hemorrhage (ICH). By elucidating the suppression of NF-κB and MAPK pathways, the findings advance stem cell-based strategies for hemorrhagic stroke recovery.
-
Lactate-GPR81/FARP1 Axis Drives Insulin-Independent Glucose
2026-07-02
This study uncovers a lactate-activated GPR81/FARP1 signaling pathway that enables skeletal muscle to increase glucose uptake independently of insulin. The findings reshape our understanding of exercise-induced glycemic control and point to new metabolic disease intervention strategies.
-
SB525334: Precision TGF-beta1 Receptor Inhibitor in Fibrosis
2026-07-01
SB525334 enables targeted, reproducible dissection of the TGF-beta1 signaling pathway in cellular and in vivo fibrosis models. This guide provides actionable workflows, advanced troubleshooting, and practical translation of recent reference study findings, positioning APExBIO’s SB525334 as an essential tool for fibrosis and chronic wound healing research.
-
VX-661 (F508del CFTR Corrector): Precision Pharmacology & Pr
2026-07-01
Explore how VX-661, a leading F508del CFTR corrector, enables precision pharmacology in cystic fibrosis research through advanced proteostasis insights, rigorous protocol strategies, and nuanced interpretation of recent calnexin-dependent rescue findings.
-
SB743921 in Cancer Research: Precision KSP Inhibition Decode
2026-06-30
Explore how SB743921, a potent kinesin spindle protein inhibitor, enables precise dissection of cell cycle arrest mechanisms in cancer research. This article uniquely connects molecular action to advanced in vitro assay design and translational outcomes.
-
Ridaforolimus (Deforolimus): Applied mTOR Inhibition in Canc
2026-06-30
Ridaforolimus (Deforolimus, MK-8669) is a potent, selective mTOR pathway inhibitor with proven efficacy as an antiproliferative and anti-angiogenic agent in diverse cancer cell lines. This guide offers actionable protocols, troubleshooting insights, and advanced workflow enhancements for researchers applying Ridaforolimus in cancer and senescence assays.
-
Machine Learning-Guided Polymer Micelles for Lung-Targeted m
2026-06-29
This study systematically dissects how the chemical structure of amine groups in polymer micelle nanoparticles governs mRNA binding, cellular uptake, and tissue-specific delivery. By combining a large experimental dataset with machine learning, the authors uncover actionable structure–activity correlations, providing a pathway for rational optimization of polymeric mRNA delivery vehicles.
-
Practical Use of Protein A/G Magnetic Beads in IP Workflows
2026-06-29
Protein A/G Magnetic Beads (SKU K1305) enable efficient, low-background antibody capture and purification from complex samples such as serum and cell culture supernatant. They are designed for immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation workflows where specificity and reproducibility are required. These beads are not intended for diagnostic or clinical use and should not be used outside research applications.
-
(-)-Arctigenin as a MEK1 Inhibitor: Applied Workflows & Assa
2026-06-28
Unlock the full potential of (-)-Arctigenin as a precision MEK1 inhibitor and iNOS expression modulator for advanced cell signaling and tumor microenvironment research. This guide delivers rigorously benchmarked protocol parameters, troubleshooting strategies, and translational insights grounded in new breast cancer microenvironment findings.